Next-generation sequencing: A transformative tool for vaccinology

TY - JOUR

T1 - Next-generation sequencing

T2 - A transformative tool for vaccinology

AU - Dhiman, Neelam

AU - Smith, David I.

AU - Poland, Gregory A.

N1 - Funding Information: Copyright Mayo Clinic (2009). This work was supported by NIH grants AI 48793, AI 33144, N01-AI 40065 and 1 UL1 RR024150-01 from the National Center for Research Resources (NCRR), a component of the NIH and the NIH Roadmap for Medical Research. Its content is solely the responsibility of the authors and does not necessarily represent the official view of the NCRR or NIH. Gregory Poland is the chair of a Safety Evaluation Committee for novel non-rubella vaccines undergoing clinical studies by Merck Research Laboratories. David Smith has a nonfunded research collaboration with Applied Biosystems. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

PY - 2009/8

Y1 - 2009/8

UR - http://www.scopus.com/inward/record.url?scp=68049144603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68049144603&partnerID=8YFLogxK

U2 - 10.1586/erv.09.67

DO - 10.1586/erv.09.67

M3 - Editorial

C2 - 19627178

AN - SCOPUS:68049144603

SN - 1476-0584

VL - 8

SP - 963

EP - 967

JO - Expert review of vaccines

JF - Expert review of vaccines

IS - 8

ER -